Literature DB >> 21146539

A structural model for apolipoprotein C-II amyloid fibrils: experimental characterization and molecular dynamics simulations.

Chai Lean Teoh1, Chi L L Pham, Nevena Todorova, Andrew Hung, Craig N Lincoln, Emma Lees, Yuen Han Lam, Katrina J Binger, Neil H Thomson, Sheena E Radford, Trevor A Smith, Shirley A Müller, Andreas Engel, Michael D W Griffin, Irene Yarovsky, Paul R Gooley, Geoffrey J Howlett.   

Abstract

The self-assembly of specific proteins to form insoluble amyloid fibrils is a characteristic feature of a number of age-related and debilitating diseases. Lipid-free human apolipoprotein C-II (apoC-II) forms characteristic amyloid fibrils and is one of several apolipoproteins that accumulate in amyloid deposits located within atherosclerotic plaques. X-ray diffraction analysis of aligned apoC-II fibrils indicated a simple cross-β-structure composed of two parallel β-sheets. Examination of apoC-II fibrils using transmission electron microscopy, scanning transmission electron microscopy, and atomic force microscopy indicated that the fibrils are flat ribbons composed of one apoC-II molecule per 4.7-Å rise of the cross-β-structure. Cross-linking results using single-cysteine substitution mutants are consistent with a parallel in-register structural model for apoC-II fibrils. Fluorescence resonance energy transfer analysis of apoC-II fibrils labeled with specific fluorophores provided distance constraints for selected donor-acceptor pairs located within the fibrils. These findings were used to develop a simple 'letter-G-like' β-strand-loop-β-strand model for apoC-II fibrils. Fully solvated all-atom molecular dynamics (MD) simulations showed that the model contained a stable cross-β-core with a flexible connecting loop devoid of persistent secondary structure. The time course of the MD simulations revealed that charge clusters in the fibril rearrange to minimize the effects of same-charge interactions inherent in parallel in-register models. Our structural model for apoC-II fibrils suggests that apoC-II monomers fold and self-assemble to form a stable cross-β-scaffold containing relatively unstructured connecting loops. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21146539     DOI: 10.1016/j.jmb.2010.12.006

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  15 in total

1.  An equilibrium model for linear and closed-loop amyloid fibril formation.

Authors:  Shuo Yang; Michael D W Griffin; Katrina J Binger; Peter Schuck; Geoffrey J Howlett
Journal:  J Mol Biol       Date:  2012-02-24       Impact factor: 5.469

2.  NBD-labeled phospholipid accelerates apolipoprotein C-II amyloid fibril formation but is not incorporated into mature fibrils.

Authors:  Timothy M Ryan; Michael D W Griffin; Michael F Bailey; Peter Schuck; Geoffrey J Howlett
Journal:  Biochemistry       Date:  2011-10-13       Impact factor: 3.162

3.  Hot spots in apolipoprotein A-II misfolding and amyloidosis in mice and men.

Authors:  Olga Gursky
Journal:  FEBS Lett       Date:  2014-02-20       Impact factor: 4.124

4.  An alternative structural isoform in amyloid-like aggregates formed from thermally denatured human γD-crystallin.

Authors:  Sean D Moran; Tianqi O Zhang; Martin T Zanni
Journal:  Protein Sci       Date:  2014-02-04       Impact factor: 6.725

Review 5.  Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights.

Authors:  Madhurima Das; Olga Gursky
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 6.  Apolipoproteins and amyloid fibril formation in atherosclerosis.

Authors:  Chai Lean Teoh; Michael D W Griffin; Geoffrey J Howlett
Journal:  Protein Cell       Date:  2011-03-12       Impact factor: 14.870

7.  Apolipoprotein C-II Adopts Distinct Structures in Complex with Micellar and Submicellar Forms of the Amyloid-Inhibiting Lipid-Mimetic Dodecylphosphocholine.

Authors:  Timothy M Ryan; Michael D W Griffin; Duncan J McGillivray; Robert B Knott; Kathleen Wood; Colin L Masters; Nigel Kirby; Cyril C Curtain
Journal:  Biophys J       Date:  2016-01-05       Impact factor: 4.033

8.  Novel Type of Renal Amyloidosis Derived from Apolipoprotein-CII.

Authors:  Samih H Nasr; Surendra Dasari; Linda Hasadsri; Jason D Theis; Julie A Vrana; Morie A Gertz; Prasuna Muppa; Michael T Zimmermann; Karen L Grogg; Angela Dispenzieri; Sanjeev Sethi; W Edward Highsmith; Giampaolo Merlini; Nelson Leung; Paul J Kurtin
Journal:  J Am Soc Nephrol       Date:  2016-06-13       Impact factor: 10.121

9.  Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis.

Authors:  Madhurima Das; Xiaohu Mei; Shobini Jayaraman; David Atkinson; Olga Gursky
Journal:  FEBS J       Date:  2014-04-28       Impact factor: 5.542

10.  "Janus" cyclic peptides: a new approach to amyloid fibril inhibition?

Authors:  Nevena Todorova; Levi Yeung; Andrew Hung; Irene Yarovsky
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.